Ablexis Competitors and Similar CompaniesClear all
Ablexis's competitors and similar companies include AbCellera Biologics, Imaxio, Memo Therapeutics and Vir Biotechnology.
 Ablexis Ablexis is a company that commercializes a transgenic mouse platform AlivaMab for human therapeutic antibody discovery. |  AbCellera Biologics AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies. |  Imaxio Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis. |  Memo Therapeutics Memo Therapeutics is a company operating in the field of antibody discovery and immune repertoire analysis. |  Vir Biotechnology Vir Biotechnology is a biopharmaceutical company that develops therapies for infectious diseases and cancer. | |
Founding Date | Founding Date 2009 | Founding Date 2012 | Founding Date 2000 | Founding Date 2012 | Founding Date 2016 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Vancouver, CA HQ | Locations Paris, FR HQ Lyon, FR | Locations Schlieren, CH HQ | Locations San Francisco, US HQ Bellinzona, CH |
Employees | Employees 1 | Employees 596 | Employees 23 | Employees 452% increase | Employees 40830% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 833.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $75.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $68.6m (FY, 2025) |
Net income | Net income N/A | Net income ($146.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($438m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 12m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 27.7m (over 2 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 12m | Total funding raised $ 115m | Total funding raised $ 3.8m | Total funding raised $ 50.5m | Total funding raised $ 637.7m |
For sources of this data, please see the company profile
View Company Profiles
AbCellera Biologics
HQ
Vancouver, CA
Employees
596
AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies.
View companyImaxio
HQ
Paris, FR
Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis.
View companyMemo Therapeutics
HQ
Schlieren, CH
Employees
45↑ 2% increase
Memo Therapeutics is a company operating in the field of antibody discovery and immune repertoire analysis.
View companyVir Biotechnology
HQ
San Francisco, US
Employees
408↓ 30% decrease
Vir Biotechnology is a biopharmaceutical company that develops therapies for infectious diseases and cancer.
View company